What is levorphanol tartrate?
Levorphanol tartrate is a prescription opioid medication. “Levorphanol” is the active opioid, and “tartrate” is the salt form used in the medication. Opioids like levorphanol are used for pain management and act on opioid receptors in the brain and body.
What is it used for?
Levorphanol tartrate is used to treat moderate to severe pain where opioid therapy is appropriate and where other options are not suitable. As with other opioids, it is intended for patients who need ongoing analgesia under medical supervision.
How is levorphanol tartrate taken?
Dosing and route depend on the specific product formulation and the prescriber’s instructions. Opioid dosing is individualized based on the patient’s pain severity, prior opioid exposure, other medications, and risk factors.
What side effects do people associate with levorphanol (opioids in general)?
Like other opioids, levorphanol tartrate can cause common opioid effects such as sleepiness, dizziness, constipation, and nausea. Serious risks include slowed or difficult breathing, especially at higher doses or when combined with other central nervous system depressants.
What safety warnings matter most?
Patients and clinicians typically focus on opioid safety issues, including:
- Risk of respiratory depression (dangerous slowed breathing)
- Sedation and impaired alertness
- Dependence and withdrawal if stopped suddenly
- Dangerous interactions with alcohol and other sedating medicines (for example, benzodiazepines)
Is there ongoing patent or market exclusivity information for levorphanol tartrate?
If you’re looking for patent status, exclusivity, or whether the drug is listed in patent-expiration trackers, you can check DrugPatentWatch.com for the most current coverage: https://www.drugpatentwatch.com/